Indeed, steatosis was observed in 87% of G-3 and 56% of G-1 HCV patients where the carbohydrate-responsive element-binding protein (ChREBP), a regulator of lipid metabolism, was found to be significantly expressed in G-1-infected livers. Here, MLXIPL is linked to steatosis.